Location: Home
  • search
  • go
  • Relate News
  • 10/13/2020KBR: Medytox Suspected of Illegally Selling BTX in China
  • 10/13/2020Rhizen Pharma and Curon Biopharma Enter License Deal for Tenalisib in ...
  • 10/13/2020China: BMI Fund Cannot Afford to Cover Vaccinations
  • 10/13/2020SAMR Solicits Comments on the Draft Guide to Antimonopoly in the Bulk ...
  • 10/12/2020CDE Issues the Clinical Requirements for Drugs Marketed Outside China ...
  • 10/11/2020Antengene Announces Collaboration with WuXi Biologics to Advance the D...
  • 10/10/2020Innovent and Lilly Announce the NMPA Approval of HALPRYZA® (Rituximab...
  • 10/10/2020NHSA and MOF Issues Joint Notice to Advance the Trial for Inter-Provin...
  • 10/9/2020China Reduces VAT on A New Batch of Anticancer Drugs
  • 10/9/2020Recent Executive Moves
  • 10/9/2020NMPA Issues the Guide to Pharmaceutical Contract Manufacture Quality A...
  • 10/8/2020Boehringer Ingelheim Pledges Continued Direct Investments in China
  • 10/8/2020Lilly and Innovent Close the Expanded Global Collaboration on TYVYT (S...
  • 10/7/2020Harbour BioMed Announces Two NMPA IND Clearances for Phase 1 & Combo ...
  • 10/4/2020Q&A with Pfizer CentreOne on Contract Manufacturing for China
  • 9/30/2020NMPA Issues the Rules for Medical Representative Filing Management
  • 9/30/2020IQVIA: Chinese Hospital Drug Market Down 15.3% in Q2/2020
  • 9/30/2020Financial-related Company News in Brief
  • 9/29/2020Beijing Court Rules Over Shareholder In-fighting of Sinovac
  • 9/29/2020Apollomics Granted Chinese IND Approval for APL-106 in Acute Myeloid L...
  • 9/29/2020TYVYT and BYVASDA Combo Study Meets Its Primary Endpoints
  • 9/29/2020JD Health Files for Hong Kong IPO
  • 9/28/2020China Resources Pharma Agrees to Acquire Plasma Company Boya Biopharma
  • 9/28/2020NMPA Issues the Registration Classification and Dossier Requirements o...
  • 9/27/2020CPA Initiates Platform to Prepare for Medical Representative Registrat...
  • 9/25/2020BioDuro and Sundia Tie Up to Become Industry Leading CRDMO
  • 9/25/2020Snapshot of R&D Spending of Listed Chinese Pharma Companies in H1/2020
  • 9/25/2020Review of Chinese Pharma Licensing Trends 2015-2019
  • 9/25/2020IQVIA: China Represents 11% of Global Vaccine Market
  • 9/25/2020Performance Review of A Share-Listed Chinese MedPharm Companies in the...
  • Page:120/371 Total number of articles:11124: [First][<<] [118] [119] [120] [121] [122] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group